The $109 Billion Fund Behind Novo Says US Renewables Are Now ‘Much More Attractive’
After curbing allocations earlier this year, the $109 billion investment fund behind Novo Nordisk A/S is back in full swing and looking for opportunities in a US market that’s now attractively priced, according to its chief executive.
We haven't written up this one. Financial Post has the full story — the link below goes straight to it.